170 related articles for article (PubMed ID: 18850097)
1. A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma.
Zanotti-Fregonara P; Grassetto G; Hindié E; Rubello D
Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):169-71. PubMed ID: 18850097
[No Abstract] [Full Text] [Related]
2. The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.
Goolden AW
Clin Endocrinol (Oxf); 1985 Jul; 23(1):81-6. PubMed ID: 3896581
[No Abstract] [Full Text] [Related]
3. Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.
Rosario PW; Mourão GF; Siman TL; Calsolari MR
Endocrine; 2015 May; 49(1):279-82. PubMed ID: 25205448
[No Abstract] [Full Text] [Related]
4. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
Giovanella L; Ceriani L; Ghelfo A; Keller F
Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
[TBL] [Abstract][Full Text] [Related]
5. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
Baskin HJ
Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
[TBL] [Abstract][Full Text] [Related]
6. Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer.
Yang X; Liang J; Li T; Zhao T; Lin Y
J Clin Endocrinol Metab; 2016 Mar; 101(3):1307-13. PubMed ID: 26789779
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum thyroglobulin levels at the time of ablative radioactive iodine therapy indicate a worse prognosis in thyroid cancer: an Australian retrospective cohort study.
Matthews TJ; Chua E; Gargya A; Clark J; Gao K; Elliott M
J Laryngol Otol; 2016 Jul; 130 Suppl 4():S50-3. PubMed ID: 27488338
[TBL] [Abstract][Full Text] [Related]
9. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
[TBL] [Abstract][Full Text] [Related]
10. An update on management of differentiated thyroid carcinoma.
Chopra IJ
Thyroidology; 1993 Aug; 5(2):57-60. PubMed ID: 7522532
[TBL] [Abstract][Full Text] [Related]
11. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
Terris DJ
Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
[No Abstract] [Full Text] [Related]
12. Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough?
Giovanella L
Head Neck; 2011 Sep; 33(9):1379-80; author reply 1380-1. PubMed ID: 21739512
[No Abstract] [Full Text] [Related]
13. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
Rosario PW
Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
[No Abstract] [Full Text] [Related]
14. Postsurgical management of differentiated thyroid carcinoma.
Mazzaferri EL; Robyn J
Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
[TBL] [Abstract][Full Text] [Related]
15. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
16. 131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated?
McDougall IR
Thyroid; 1997 Aug; 7(4):669-72. PubMed ID: 9292959
[TBL] [Abstract][Full Text] [Related]
17. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma.
Lee JI; Chung YJ; Cho BY; Chong S; Seok JW; Park SJ
Surgery; 2013 Jun; 153(6):828-35. PubMed ID: 23489940
[TBL] [Abstract][Full Text] [Related]
18. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.
Wang TS; Evans DB; Fareau GG; Carroll T; Yen TW
Ann Surg Oncol; 2012 Dec; 19(13):4217-22. PubMed ID: 23010732
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
[TBL] [Abstract][Full Text] [Related]
20. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]